Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina

Simple item page
dc.contributor.authorSciannameo, Sergio
dc.contributor.authorZalazar, Virginia
dc.contributor.authorSpadaccini, Luciana
dc.contributor.authorDuarte, Mariana
dc.contributor.authorCahn, Pedro
dc.contributor.authorAristegui, Ines
dc.contributor.authorSued, Omar
dc.date.accessioned2024-04-11T14:18:29Z
dc.date.available2024-04-11T14:18:29Z
dc.date.issued2024-02
dc.description.abstractBackground: Little is known about the preferences for antiretroviral therapy (ART) administration methods, such as oral daily pills or long-acting injectable (LAI) options, as well as preferences for pre-exposure prophylaxis (PrEP) administration methods among people without HIV in Latin America. Objectives: This study aimed to assess the preferences for ART administration methods among people with HIV and PrEP methods among those without HIV, as well as to examine the correlations and reasons for these preferences. Design: We conducted a cross-sectional web-based questionnaire between April and July 2021, using social media accounts of a HIV non-governmental organization. The questionnaire was open to all adults living in Argentina, irrespective of their sexual orientation or gender identity. Methods: The questionnaire included questions on substance use, depression, chronic treatment, previous experiences with injectable medication, and HIV status. Those with HIV answered questions about ART adherence and their preferences for ART methods, while those without HIV were asked about condom use, awareness of PrEP, and their preferences for PrEP methods. Results: Out of 1676 respondents, 804 had HIV, and 872 did not. Among those with HIV, 91.5% expressed a high preference for LAI-ART, with significantly higher preferences among participants with higher educational levels, cisgender gay, bisexual, and queer men, younger individuals, and those with prior injectable medication experience. Among those without HIV, 68% preferred LAI-PrEP, and this preference was positively associated with previous positive experiences with injectable medication. Conclusion: The strong preference for LAI-ART suggests the potential for improved adherence and well-being among people with HIV. Additionally, the preference for LAI-PrEP among those without HIV emphasizes the importance of considering this option for HIV prevention strategies. This study highlights the need to offer diverse methods for ART and prevention to accommodate different preferences and improve health care outcomes in Latin America.
dc.identifier.citationSciannameo S., Zalazar V., Spadaccini L., Duarte M., Cahn P., Aristegui I. & Sued O. (2024). Preference for long acting injectable (LAI) antiretrovirals in Argentina. Therapeutic Advances in Infectious Disease, aceptado
dc.identifier.issn2049-937X
dc.identifier.urihttps://repositorio.huesped.org.ar/handle/123456789/959
dc.languagees
dc.language.isoen
dc.subjectantiretroviral therapy
dc.subjectLatin America
dc.subjectlong-acting injectable
dc.subjectpatient preference
dc.subjectpre-exposure
dc.subjectprophylaxis
dc.titlePreference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2024_Sciannameo_Preference for ART administration among people with HIV and PrEP methods among those without HIV (1).pdf
Size:
806.29 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Articulos científicos